Dr. Chung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
120 Dillon Dr
Spartanburg, SC 29307Phone+1 864-699-5700Fax+1 864-699-5701
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1999 - 2003
- Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1999
- University of North Carolina at Chapel Hill School of MedicineClass of 1995
Certifications & Licensure
- SC State Medical License 2011 - 2025
- NY State Medical License 1999 - 2013
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Clinical Trials
- Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer Start of enrollment: 2011 Apr 01
- Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300) Start of enrollment: 2015 Dec 28
- Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL) Start of enrollment: 2016 Mar 01
Publications & Presentations
PubMed
- 202 citationsctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper.Arvind Dasari, Van K. Morris, Carmen J. Allegra, Chloe E. Atreya, Al B. Benson
Nature Reviews. Clinical Oncology. 2020-07-06 - 116 citationsEpidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study.Jinru Shia, David S. Klimstra, Allan R. Li, Jing Qin, Leonard B. Saltz
Modern Pathology. 2005-10-01 - 864 citationsCetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by ImmunohistochemistryKi Y. Chung, Jinru Shia, Nancy E. Kemeny, Manish A. Shah, Gary K. Schwartz
Journal of Clinical Oncology. 2005-03-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: